TMEM97 and prostate carcinoma: TMEM97 mRNA and/or proteins was significantly increased in breast, colon, gastric, esophageal, lung, ovarian cancer and prostate cancer [27,28,29,30,31,32,33,34,35,36], but decreased in meningiomas, pancreatic and renal cancer [27,37].